Yellow fever pre-vaccination checklist updated

Updates to the pre-vaccination checklist have been made in line with the new 'green book' yellow fever chapter
Yellow fever pre-vaccination checklist updated

The yellow fever pre-vaccination checklist has been updated in line with the 'green book' immunisation against infectious disease, yellow fever chapter 35. Edits have been made to the supporting text on pages 3 and 4 including:

  • New wording highlighting those with an ongoing allergy to egg may need to be assessed by a trained allergy specialist or immunologist and vaccinated in a hospital setting.
  • New wording on open chest surgery and possible removal of the thymus gland.
  • Minor edit to the section on first degree family members with history of serious adverse reaction to yellow fever vaccine to clarify meaning.

Advice for health professionals

Staff working in designated yellow fever vaccination centres (YFVCs) should ensure they are using the updated version.

The checklist has been produced by the National Travel Health Network and Centre (NaTHNaC) and Public Health Scotland (PHS) in accordance with the recommendations in the Commission on Human Medicine's Expert Working Group report.

The checklist is a tool designed to:

  • Help the healthcare professional risk assess a person's suitability for yellow fever vaccination.
    • It does not replace the broader individual risk assessment in the travel health consultation.
  • Be completed by the person travelling in advance of, or during, the travel health consultation.
    • But must be carefully reviewed by the advising healthcare professional as part of a shared decision-making process for yellow fever vaccination.

The checklist and instructions for using the interactive PDF document can be found on TravelHealthPro and the Yellow Fever Zone.


Search by


Explore more

Marburg virus disease in Ethiopia

On 26 January 2026, the Ministry of Health of Ethiopia declared the end of the Marburg virus disease outbreak

Updated: 05 February 2026

ABTA Destinations to Watch report published

ABTA has launched its Destinations to Watch report for 2026

Updated: 03 February 2026

Mefloquine shortage

Shortage of 250mg mefloquine (Lariam) antimalarial tablets in the United Kingdom (UK) until the end of March 2026

Updated: 30 January 2026

NaTHNaC Telephone Advice Line for health professionals

Additional advice line sessions are planned, starting in January 2026

Updated: 21 January 2026

Country Information updates: Japanese encephalitis vaccine recommendations

NaTHNaC has reviewed and updated the Japanese encephalitis (JE) country-specific information and vaccine recommendations

Updated: 19 January 2026